Compare SEZL & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SEZL | BLFS |
|---|---|---|
| Founded | 2016 | 1987 |
| Country | United States | United States |
| Employees | N/A | 155 |
| Industry | Diversified Financial Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 1.8B |
| IPO Year | 2023 | 2013 |
| Metric | SEZL | BLFS |
|---|---|---|
| Price | $111.75 | $38.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $109.33 | $32.00 |
| AVG Volume (30 Days) | 444.7K | ★ 841.2K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | ★ 2.64 | 0.94 |
| Revenue | ★ $450,279,000.00 | $96,214,000.00 |
| Revenue This Year | $30.30 | $19.73 |
| Revenue Next Year | $24.79 | $17.82 |
| P/E Ratio | $41.58 | ★ $41.38 |
| Revenue Growth | ★ 66.08 | 16.97 |
| 52 Week Low | $49.50 | $17.86 |
| 52 Week High | $195.71 | $38.91 |
| Indicator | SEZL | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 40.63 | 67.60 |
| Support Level | $57.15 | $34.38 |
| Resistance Level | $114.14 | N/A |
| Average True Range (ATR) | 5.24 | 0.87 |
| MACD | 0.16 | 0.17 |
| Stochastic Oscillator | 38.88 | 92.05 |
Sezzle Inc is a financing institution that offers technology-driven payment platform. The Sezzle Platform offers a payments solution for consumers in the United States and Canada that has the ability to instantly extend credit at the point-of-sale, allowing consumers to purchase and receive merchandise while paying in installments over time. Consumers pay a portion of the purchase price at the point-of-sale as a down payment, and then pay off the remaining amount over time through scheduled payments. It also offer the ability to pay-in-full using the Sezzle Platform. Its operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.